Table 2 MBPT Positivity and FeNO 20 PPB Rates of the Study Patients Grouped According to Act Scores at Baseline and Follow Up
Totally controlled | Partially controlled | Uncontrolled | |||||
|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | p | |
Baseline | (n = 8) | (n = 36) | (n = 39) | ||||
MBPT positivity | 5 | 62% | 20 | 56% | 24 | 62% | 0.852 |
FeNO > 20 ppb | 3 | 38% | 19 | 53% | 10 | 25% | 0.054 |
3rd month follow up | (n = 10) | (n = 39) | (n = 34) | ||||
MBPT positivity | 3 | 30% | 21 | 54% | 13 | 38% | 0.250 |
FeNO > 20 ppb | 2 | 20% | 10 | 26% | 13 | 38% | 0.381 |